[TechWeb] March 14 news, a few days ago, JD Health and the first batch of domestic FDA "COVID-19 antigen self-test" product approval of a number of enterprises reached sales cooperation. The first batch of COVID-19 antigen self-test products will be booked on JD Health's opening line in the near future. At that time, consumers can make an appointment through JD.com APP search for "COVID-19 Antigen self-Test" to the details page, and an order can be issued for purchase when the goods are officially on sale.

On March 11, the Comprehensive team of the Joint Prevention and Control Mechanism of the State Council formally released the novel coronavirus Antigen Detection Application Plan (trial) (hereinafter referred to as the "Program") to promote the monitoring mode of "Antigen screening and Nucleic Acid diagnosis". Antigen detection is added as a supplement to nucleic acid testing.

The "plan" proposes that three types of personnel can do antigen testing: those who go to grass-roots medical and health institutions with respiratory tract, fever and other symptoms within five days; and isolation and observation personnel, including those in home isolation observation, close and sub-close contact, entry isolation observation, sealed control areas and control areas, and community residents who need antigen self-testing.

Since the epidemic, JD Health has given full play to the ability of medical services, launched a series of services such as knowledge popularization, online consultation, and psychological counseling, and worked with local testing institutions and brand partners to upgrade online booking services to actively help prevent and control the epidemic and protect public health.